
First global patient takes part in trial of new drug to treat rare inflammatory muscle disease
The first global patient has taken part in a clinical trial testing the effectiveness and safety of a new treatment for a rare inflammatory muscle disease. Professor Hector Chinoy is the UK chief investigator of the study and Dr James Lilleker is a sub-investigator. Both are BRC researchers within
Continue reading full article: First global patient takes part in trial of new drug to treat rare inflammatory muscle disease